Scientists map hidden diversity in rare childhood tumors
NCT ID NCT04987476
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at tumor samples from 15 children with rhabdoid tumors to understand why some parts of the tumor resist treatment. By analyzing individual cells, researchers aimed to identify different cell types within each tumor and find potential new targets for therapy. The study did not test any new treatment, but gathered information to guide future drug development.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Curie
Paris, 75005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeted radiation zaps childhood brain tumors in early trial
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- New hope for kids with Hard-to-Treat cancers: targeted drug shows promise
- New drug targets tough childhood cancers with genetic flaws
- New stem cell transplant shows promise for kids with tough cancers
- Immunotherapy drug nivolumab takes on rare childhood cancer